Literature DB >> 2044222

Phenotype and immunoglobulin gene configuration of blood B cells from patients with multiple myeloma.

Y Levy1, C Schmitt, A Tsapis, J C Brouet, J P Fermand.   

Abstract

We have studied the phenotype and the immunoglobulin gene configuration of blood B cells from 15 patients with stage III multiple myeloma (MM) at diagnosis. Highly purified B cells (greater than 90% CD20 positive cells) were obtained after L-leucine methyl ester monocyte depletion and elimination of T cells by rosetting. The percentage of B cells with surface immunoglobulin (sIg) featuring the same light and heavy chain isotype as the serum monoclonal immunoglobulin was very low, except in one patient, in whom 25-30% of B cells displayed surface and cytoplasmic immunoglobulin (cIg) sharing idiotypic determinants with the serum monoclonal IgG kappa. In all cases but one the percentage of circulating plasma cells accounted for less than 2% of the enriched B cell preparations. In one patient purified B cell population contained 30% of plasma cells and the immunoglobulin gene study revealed a rearranged JH hybridizing fragment identical in bone marrow and blood B cell DNA samples. In the other 14 cases no rearranged fragment was detected although we used a technique allowing the detection of at least 2% clonal cells. The absence of clonal cells in the patient whose B cells contained a high percentage of cells featuring surface IgG molecules was confirmed on purified sIgG-positive cells. In addition CD20-positive cells from this patient did not contain gamma mRNA. Therefore the IgG molecules were clearly extrinsic. Although the existence of clonal B lymphocytes or of myeloma idiotype related B cells cannot be ruled out, they escape detection by sensitive genetic studies of immunoglobulin genes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2044222      PMCID: PMC1535434     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  20 in total

1.  The monoclonal nature of lymphocytes in multiple myeloma. Effects of therapy.

Authors:  N I Abdou; N L Abdou
Journal:  Ann Intern Med       Date:  1975-07       Impact factor: 25.391

2.  Studies on the origin of the precursor cells in multiple myeloma, Waldenström's macroglobulinaemia and benign monoclonal gammopathy. I. Cytoplasmic isotype and idiotype distribution in peripheral blood and bone marrow.

Authors:  B Van Camp; P Reynaert; L Broodtaerts
Journal:  Clin Exp Immunol       Date:  1981-04       Impact factor: 4.330

3.  Idiotypic peripheral blood lymphocytes in monoclonal gammopathy.

Authors:  E J Bast; B van Camp; P Reynaert; G Wiringa; R E Ballieux
Journal:  Clin Exp Immunol       Date:  1982-03       Impact factor: 4.330

4.  Immunofluorescent staining of human lymphocytes for the detection of surface immunoglobulins.

Authors:  J L Preud'homme; S Labaume
Journal:  Ann N Y Acad Sci       Date:  1975-06-30       Impact factor: 5.691

5.  Idiotypic lymphocytes in human monoclonal gammopathies.

Authors:  M Boccadoro; A Van Acker; A Pileri; J Urbain
Journal:  Ann Immunol (Paris)       Date:  1981 Jan-Feb

6.  Idiotype-bearing peripheral blood lymphocytes in human multiple myeloma and Waldenström's macroglobulinaemia.

Authors:  I Schedel; D Peest; K Stünkel; M Fricke; G Eckert; H Deicher
Journal:  Scand J Immunol       Date:  1980       Impact factor: 3.487

7.  gamma Heavy chain disease in man: cDNA sequence supports partial gene deletion model.

Authors:  A Alexander; M Steinmetz; D Barritault; B Frangione; E C Franklin; L Hood; J N Buxbaum
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

Review 8.  Monoclonal gammopathies: new approaches to clinical problems in diagnosis and prognosis.

Authors:  P R Greipp
Journal:  Blood Rev       Date:  1989-12       Impact factor: 8.250

9.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

10.  Studies on the clonal origin of multiple myeloma. Use of individually specific (idiotype) antibodies to trace the oncogenic event to its earliest point of expression in B-cell differentiation.

Authors:  H Kubagawa; L B Vogler; J D Capra; M E Conrad; A R Lawton; M D Cooper
Journal:  J Exp Med       Date:  1979-10-01       Impact factor: 14.307

View more
  4 in total

1.  Novel analysis of clonal diversification in blood B cell and bone marrow plasma cell clones in immunoglobulin light chain amyloidosis.

Authors:  Roshini S Abraham; Michelle K Manske; Neta S Zuckerman; Abhishek Sohni; Hanna Edelman; Gitit Shahaf; Michael M Timm; Angela Dispenzieri; Morie A Gertz; Ramit Mehr
Journal:  J Clin Immunol       Date:  2006-12-28       Impact factor: 8.317

2.  A reappraisal of immunoglobulin variable gene primers and its impact on assessing clonal relationships between PB B cells and BM plasma cells in AL amyloidosis.

Authors:  Nagaaki Katoh; Tanya L Poshusta; Michelle K Manske; Angela Dispenzieri; Morie A Gertz; Roshini S Abraham; Marina Ramirez-Alvarado
Journal:  J Clin Immunol       Date:  2011-09-10       Impact factor: 8.317

3.  Normal and clonal B lineage cells can be distinguished by their differential expression of B cell antigens and adhesion molecules in peripheral blood from multiple myeloma (MM) patients--diagnostic and clinical implications.

Authors:  R Luque; J A Brieva; A Moreno; A Manzanal; L Escribano; J Villarrubia; J L Velasco; J López-Jiménez; C Cerveró; M J Otero; J Martínez; C Bellas; E Roldán
Journal:  Clin Exp Immunol       Date:  1998-06       Impact factor: 4.330

4.  The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to the malignant plasma cell.

Authors:  D Billadeau; G Ahmann; P Greipp; B Van Ness
Journal:  J Exp Med       Date:  1993-09-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.